ADAPTIVE BIOTECHNOLOGIES
Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. It was founded in 2009 and headquartered in Seattle, Washington.
ADAPTIVE BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.adaptivebiotech.com
Total Employee:
501+
Status:
Active
Contact:
(206) 659-0067
Email Addresses:
[email protected]
Total Funding:
531.85 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network SSL By Default Organization Schema Cloudflare Hosting
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-01-07 | Sequenta | Sequenta acquired by Adaptive Biotechnologies | N/A |
Investors List
OrbiMed
OrbiMed investment in Post-IPO Debt - Adaptive Biotechnologies
ARK Investment Management
ARK Investment Management investment in Post-IPO Equity - Adaptive Biotechnologies
Sweetwater Capital Partners
Sweetwater Capital Partners investment in Post-IPO Equity - Adaptive Biotechnologies
EquityZen
EquityZen investment in Secondary Market - Adaptive Biotechnologies
Senator Investment Group
Senator Investment Group investment in Series F - Adaptive Biotechnologies
Tiger Management Corporation
Tiger Management Corporation investment in Series F - Adaptive Biotechnologies
Matrix Capital Management
Matrix Capital Management investment in Series F - Adaptive Biotechnologies
Rock Springs Capital
Rock Springs Capital investment in Series F - Adaptive Biotechnologies
Viking Global Investors
Viking Global Investors investment in Series D - Adaptive Biotechnologies
Viking Global Investors
Viking Global Investors investment in Series C - Adaptive Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.adaptivebiotech.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.94 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adaptive Biotechnologies"
Who We Are - Adaptive Biotech
In 2009, Harlan Robins made a breakthrough that created a window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded …See details»
Adaptive Biotechnologies - Crunchbase Company …
Contact Email [email protected] Phone Number (206) 659-0067 Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive …See details»
Adaptive Biotechnologies Corp. | LinkedIn
Adaptive Biotechnologies Corp. | 29,662 followers on LinkedIn. Every immune system has a story to tell; the key is knowing how to listen. | Adaptive Biotechnologies is a pioneer and leader in ...See details»
Our Story - Adaptive Biotech
Our Innovation Timeline. Just as our immune systems have evolved, shaped by our environment and biology, so has Adaptive Biotechnologies. Our progress has accelerated our ability to read the immune story within each of us and apply …See details»
Adaptive Biotechnologies Corp: Overview - GlobalData
Website www.adaptivebiotech.com Telephone 1 206 6590067. No of Employees 709. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange ADPT (NASD) Revenue (2023) …See details»
Adaptive Biotechnologies - Overview, News & Similar companies ...
May 26, 2024 Adaptive Biotechnologies contact info: Phone number: (206) 659-0067 Website: www.adaptivebiotech.com What does Adaptive Biotechnologies do? Founded in 2009, …See details»
Adaptive Biotechnologies - Golden
Organization. Company attributes. Industry. Medical diagnostics. Healthcare. Immunotherapy. Therapeutics. Vaccine. Drug discovery. ... [email protected] 0. Phone Number …See details»
Adaptive Biotechnologies Company Profile | Management and
SQL International Organization for Standardization . C# Microsoft . Apache Groovy Apache Corporation . Java Oracle . PHP PHP . Perl Perl.com . Python Python . Operating Systems (6 …See details»
Adaptive Biotechnologies Revonect Business Profile
Adaptivebiotech.com. Adaptive Biotechnologies. Office phone +1 206-659-0*** Homepage https://www.adaptivebiotech.com ... Manage your Business. We are a commercial-stage, …See details»
Adaptive Biotechnologies Announces Grand Opening of State-of …
Sep 21, 2021 New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech Talent. SEATTLE, Sept. 21, 2021 (GLOBE …See details»
Press Releases - Adaptive Biotechnologies
The Investor Relations website contains information about Adaptive Biotechnologies's business for stockholders, potential investors, and financial analysts.See details»
Adaptive Biotechnologies Corp. (Adaptive Biotechnologies Corp.)
Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com. About Adaptive …See details»
Working at Adaptive Biotechnologies - Zippia
Mar 14, 2024 www.adaptivebiotech.com. Organization Type. Public. CEO. Chad Robins. Social Media. Adaptive Biotechnologies is a commercial-stage company advancing the field of …See details»
Corporate Social Responsibility - Adaptive Biotech
ERG Spotlights Adaptive Pride Adaptive and the Pride ERG celebrated receiving a score of 80 out of 100 on the Human Rights Campaign Foundation’s 2025 Corporate Equality Index (CEI), the …See details»
Press Release Details - Adaptive Biotechnologies
[email protected]. ADAPTIVE INVESTORS Karina Calzadilla, Vice President, Investor Relations 201-396-1687 Carrie Mendivil, Gilmartin Group [email protected]. …See details»
Press Release Details - investors.adaptivebiotech.com
SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the …See details»
Adaptive Biotechnologies and NeoGenomics Partner to Expand …
1 day ago [email protected]. Adaptive Media Contact: Erica Jones, Associate Director, Corporate Communications 206-279-2423 [email protected] …See details»
Timeline - Adaptive Biotech
Timeline. Scroll through Adaptive Biotechnologies’ timeline and learn how we have arrived at the precipice of transforming medicine. Our milestones show how we are harnessing the natural …See details»
Create Account - Adaptive Biotech
Get started by creating an immunoSEQ Analyzer account. Create Account. First Name:See details»
Platform - Adaptive Biotech
Finding the Answers Within Us Our Immune Medicine Platform makes the adaptive immune system accessible by applying proprietary chemistry, computational biology and machine …See details»